Industry News
A Michigan woman with motor neuron disease has received the first Paradromics Connexus brain implant
Paradromics announced on 17 June 2026 that University of Michigan surgeons have implanted its Connexus brain-computer interface in a woman with motor neuron disease, the first patient in the FDA-approved Connect-One early feasibility study. She will be followed for six years.